We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TWO:NYSETwo Harbors Investment Corp Analysis

Data as of 2026-09-01 - not real-time

$12.18

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Two Harbors Investment Corp. trades at $12.18, with its moving averages tangled rather than clearly stacked — a neutral trend structure. With RSI at 61.2 the momentum picture is approaching overbought, alongside a bullish MACD signal. Watch $11.98 as support and $12.19 as the nearer resistance level.
Multiples put this in undervalued territory: 10.3 times earnings against the sector's 32.0. Revenue is growing at 620.2% on a -3.4% profit margin. The 11.17% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 5.3%, a beta of 0.17 and a maximum drawdown of 36.8%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

Seeking Alpha1monTwo Harbors Investment's Q2 earnings meet consensus in last quarter as a publicly traded companyTwo...NEW YORK, July 23, 2026--TWO Announces Third Quarter 2026 Stub Period Dividend on Common StockNasdaq20dTWO Responds to Baseless Claims by UWMCNEW YORK-- BUSINESS WIRE -- TWO Two Harbors Investment Corp.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 11.40
  • MACD momentum is positive
  • Maximum drawdown of 36.8%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 10.3 versus sector average of 32.0
  • Trading above the 200-day average of 11.40
  • MACD momentum is positive

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 10.3 versus sector average of 32.0
  • Negative profit margin of -3.4%
  • Negative return on equity of -1.2%

Key Metrics & Analysis

Financial Health

Revenue Growth620.20%
Profit Margin-3.39%
P/E Ratio10.3
ROE-1.19%
ROA-0.20%
Debt/Equity379.40
P/B Ratio1.1
Op. Cash Flow$127.2M
Industry P/E32.0

Technical Analysis

TrendNeutral
RSI61.2
Support$11.98
Resistance$12.19
MA 20$12.06
MA 50$12.14
MA 200$11.40
MACDBullish
VolumeStable
Fear & Greed Index93.18

Valuation

Target Price$11.91
Upside/Downside-2.26%
GradeUndervalued
TypeValue
Dividend Yield11.17%

Risk Assessment

Beta0.17
Volatility5.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.